BMS-986504

Clinical trials for BMS-986504 explained in plain language.

Never miss a new study

Get alerted when new BMS-986504 trials appear

Sign up with your email to follow new studies for BMS-986504, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug trial targets aggressive pancreatic Cancer's genetic weakness

Disease control Terminated

This study is testing if adding an experimental drug called BMS-986504 to standard chemotherapy helps control pancreatic cancer in people whose tumors have a specific genetic change called an MTAP deletion. It aims to see if the combination is safe and can slow cancer growth or i…

Matched conditions: BMS-986504

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

BMS-986504

Get alerted when new BMS-986504 trials appear

New drug trial targets aggressive pancreatic Cancer's genetic weakness